Radiopaque polymers
AssigneeBoston Scientific Medical Device Limited
InventorsStephane Hohn, Andrew Lennard Lewis, Sean Leo Willis, Matthew R. Dreher, Koorosh Ashrafi, Yiqing Tang
Life of this patent
Estimating the term…
Abstract
Radiopaque hydrogels, in particular radiopaque hydrogel microspheres, comprising a polymer having 1,2-dil or 1,3-diol groups acetalized with radiopaque species.
Claims18
A method of treatment in which a hydrogel is administered into a blood vessel of a patient to embolize said blood vessel, the hydrogel being in the form of microspheres comprising a cross-linked polymer network that comprises polyvinyl alcohol (PVA) or a copolymer of PVA and a radiopaque species comprising one or more covalently bound iodines that are coupled to the PVA or copolymer of PVA through a cyclic acetal group and that provides the microspheres with greater than 15 mg of iodine per ml of microspheres fully hydrated in normal saline as a packed volume wherein the radiopaque species comprises an iodinated aromatic group.
A method of treatment in which a composition is administered into a blood vessel of a patient to embolize said blood vessel, the composition comprising (a) hydrogel in the form of microspheres comprising a cross-linked polymer network that comprises polyvinyl alcohol (PVA) or a copolymer of PVA and a radiopaque species comprising one or more covalently bound iodines that are coupled to the PVA or copolymer of PVA through a cyclic acetal group and that provides the microspheres with greater than 15 mg of iodine per ml of microspheres fully hydrated in normal saline as a packed volume and (b) a therapeutic agent, wherein the therapeutic agent is absorbed into the microspheres wherein the radiopaque species comprises an iodinated aromatic group.
A method of treatment in which a hydrogel is administered into a blood vessel of a patient to embolize said blood vessel, the hydrogel having a net charge at physiological pH in the form of microspheres having a mean diameter size range of from 10 to 2000 m and comprising a cross-linked polymer network that comprises polyvinyl alcohol (PVA) or a copolymer of PVA and a radiopaque species comprising an iodinated aromatic group that is coupled to the PVA or copolymer of PVA through a cyclic acetal group and that provides the microspheres with greater than 50 mg of iodine per ml of microspheres fully hydrated in normal saline as a packed volume.
Dependencies are inferred from the claim text.